Radioactive iodine in the treatment of Grave's disease

Saudi Medical Journal

Volumn 23, Issue 9, 2002, Pages 1049-1053

  Al Kaabi, Juma M ^a,b   Hussein, Samir S ^a   Bukheit, Charles S ^a   Woodhouse, Nicholas J ^a   Elshafie, Omiema T ^a   Bererhi, Haddia ^a  

^a SULTAN QABOOS UNIVERSITY HOSPITAL   (Oman)

^b Department of Medicine ^*  (Oman)

Author keywords

Graves'; Hyperthyroidism; Iodine; Radioactive; Therapy

Indexed keywords

ANTITHYROID AGENT; IODINE 131; TECHNETIUM 99M; THYROXINE;

ADULT; AGE DISTRIBUTION; ARTICLE; CHEMICAL ANALYSIS; CONTROLLED STUDY; DOSE RESPONSE; DRUG COST; DRUG EFFICACY; EUTHYROIDISM; FEMALE; FOLLOW UP; GRAVES DISEASE; HUMAN; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; OMAN; PATIENT REFERRAL; PRACTICE GUIDELINE; SEX DIFFERENCE; THYROID CRISIS; THYROID SCINTISCANNING; THYROIDITIS; UNIVERSITY HOSPITAL;

ADULT; FEMALE; GRAVES DISEASE; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SAUDI ARABIA; TREATMENT OUTCOME;

EID: 0036757328     PISSN: 03795284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Becker DV, Sawin CT. Radio iodine and thyroid disease: The beginning. Semin Nucl Med 1996; 26: 155-164.
2. Sawin CT, Becker DV. Radio iodine and the treatment of hyperthyroidism: The early history. Thyroid 1997; 7: 163-176.
3. Shapiro B. Optimization of radioiodine therapy of thyrotoxicosis: What have we learned after 50 years? J Nucl Med 1993; 34: 1638-1641.
4. Kaplan MM, Meier DA, Dworkin HJ. Treatment of hyperthyroidism with radioactive iodine. Endocrinol Metab Clin North Am 1998; 27: 205-223.
5. McNeil D. Epidemiological Research Methods. 1st ed. New York (NY): Wiley Series in Probability and Statistics; 1996.
6. Statistical Package for Social Sciences (SPSS) Base 10.00. Chicago (IL): SPSS Inc; 1999.
7. Levy EG. Treatment of Graves' disease: The American way. Baillieres Clin Endocrinol Metab 1997; 11: 585-595.
8. Bochisch A, Jamitzky T, Derwanz R, Biersack J. Optimized dose planning of radioioiodine therapy of benign thyroidal diseases. J Nucl Med 1993; 34: 1632-1638.
9. Wartofsky L, Glinoer D, Solomon B, Nagataki S, Lagasse R, Nagayama Y et al. Differences and similarities in the diagnosis and treatment of Graves' disease in Europe, Japan, and the United States. Thyroid 1991; 1: 129-135.
10. 131I treatment of hyperthyroidism: Experience at King Faisal Specialist Hospital and Research Centre. Annals of Saudi Medicine 1988; 8: 466-469.
11. Child DF, Mughni MA, Hudson P, Williams CP, Harvey JN. Hyperthyroidism and radio-iodine therapy in a district general hospital. J R Soc Med 1994; 87: 578-580.
12. Wise PH, Burnet RB, Ahmad A, Harding PE. Intentional radioiodine ablation in Graves' disease. Lancet 1975; 2: 1231-1233.
13. Scott GR, Forfar JC, Toft AD. Graves' disease and atrial fibrillation: The case for even higher doses of therapeutic iodine-131. Br Med J (Clin Res Ed) 1984; 289: 399-400.
14. 131I therapy for thyrotoxicosis. J Clin Endocrinol Metab 1974; 39: 607-609.
15. Korber C, Schneider P, Korber-Hafner N, Hanscheid H, Reiners C. Antithyroid drugs as a factor influencing the outcome of radio iodine therapy in Graves' disease and toxic nodular goitre? Eur J Nucl Med 2001; 28: 1360-1364.